Motexafin gadolinium (MGd) overcomes adverse survival effect of anemia in brain metastases (BM) patients treated with whole brain radiation therapy (WBRT): analysis of a phase III randomized trial Journal Articles uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Kumar, P
  • Mehta, MP
  • Rodrigus, P
  • Suh, J
  • Sagar, Stephen
  • Kunkler, I
  • Carrie, C
  • Smith, JA
  • Phan, S
  • Renschler, MF

publication date

  • October 2003